This review summarizes the pathophysiologic role of endothelin in heart failure and the potential therapeutic use of endothelin receptor antagonists.
No takes yet. Share an insight, caveat, or question.
Endothelin antagonists remain investigational in heart failure; review leaves clinical efficacy open pending randomized trials.
Barry Greenberg (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: